174 related articles for article (PubMed ID: 23812773)
1. Does bethesda category predict aggressive features in malignant thyroid nodules?
Kleiman DA; Beninato T; Soni A; Shou Y; Zarnegar R; Fahey TJ
Ann Surg Oncol; 2013 Oct; 20(11):3484-90. PubMed ID: 23812773
[TBL] [Abstract][Full Text] [Related]
2. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
3. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
4. Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Hier J; Avior G; Pusztaszeri M; Krasner JR; Alyouha N; Forest VI; Hier MP; Mlynarek A; Richardson K; Sadeghi N; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):29. PubMed ID: 33910629
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative frozen section can be reduced in thyroid nodules classified as Bethesda categories V and VI.
Huang J; Luo J; Chen J; Sun Y; Zhang C; Xu K; Ye Q; Huang P
Sci Rep; 2017 Jul; 7(1):5244. PubMed ID: 28701706
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
[TBL] [Abstract][Full Text] [Related]
7. Association of Bethesda category and molecular mutation in patients undergoing thyroidectomy.
Mascarella MA; Peeva M; Forest VI; Pusztaszeri MP; Avior G; Tamilia M; Mlynarek AM; Hier MP; Payne RJ
Clin Otolaryngol; 2022 Jan; 47(1):75-80. PubMed ID: 34510770
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of the Bethesda System for conventional papillary thyroid carcinoma.
Gweon HM; Koo HR; Son EJ; Kim JA; Youk JH; Hong SW; Lim BJ
Head Neck; 2016 Oct; 38(10):1509-14. PubMed ID: 27062195
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Characteristics of Thyroid Nodules Positive for the
Morariu EM; McCoy KL; Chiosea SI; Nikitski AV; Manroa P; Nikiforova MN; Nikiforov YE
Thyroid; 2021 Aug; 31(8):1212-1218. PubMed ID: 33487086
[No Abstract] [Full Text] [Related]
10. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
[TBL] [Abstract][Full Text] [Related]
11. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management.
Logani S; Gupta PK; LiVolsi VA; Mandel S; Baloch ZW
Diagn Cytopathol; 2000 Dec; 23(6):380-5. PubMed ID: 11074641
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups.
García Pascual L; Surralles ML; Morlius X; Garcia Cano L; González Mínguez C
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):577-583. PubMed ID: 30262240
[TBL] [Abstract][Full Text] [Related]
13. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients.
Arva NC; Deitch SG
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):753-60. PubMed ID: 25879311
[TBL] [Abstract][Full Text] [Related]
14. Cytomorphological Analysis of Thyroid Nodules Diagnosed as Follicular Variant of Papillary Thyroid Carcinoma: a Fine Needle Aspiration Study of Diagnostic Clues in 42 Cases and the Impact of Using Bethesda System in Reporting-an Institutional Experience.
Trabzonlu L; Paksoy N
Endocr Pathol; 2018 Dec; 29(4):351-356. PubMed ID: 30315491
[TBL] [Abstract][Full Text] [Related]
15. Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules.
Elomami A; Elhag SA; Alseddeeqi E
Acta Cytol; 2021; 65(3):205-212. PubMed ID: 33524971
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma.
Kim MJ; Won JK; Jung KC; Kim JH; Cho SW; Park DJ; Park YJ
Thyroid; 2018 Mar; 28(3):311-318. PubMed ID: 29343212
[TBL] [Abstract][Full Text] [Related]
17. The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage.
Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Strupas K
Langenbecks Arch Surg; 2017 Mar; 402(2):227-234. PubMed ID: 28160058
[TBL] [Abstract][Full Text] [Related]
18. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between the Bethesda system for thyroid nodules and post-thyroidectomy histopathological diagnosis].
Kraus-Fischer G; Alvarado-Bachmann R; Rienzo-Madero B; Núñez-García E; Peña MV; Zerrweck-López C
Rev Med Inst Mex Seguro Soc; 2020 Apr; 58(2):114-121. PubMed ID: 34101555
[TBL] [Abstract][Full Text] [Related]
20. Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
Turkdogan S; Pusztaszeri M; Forest VI; Hier MP; Payne RJ
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32916807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
